CDMO (contract development and manufacturing organization) is undoubtedly the new mainstream of international biomedicine and the development wave is on the rise. Instant Nanobiosensors Co. Ltd and Sartorius International Pharmaceutical Equipment Supplier were invited by Global Bio & Investment Monthly and Development Center for Biotechnology (DCB) in a webinar to share thoughts on how Taiwan's CDMO industry can improve and compete globally. The webinar mentioned opportunities for pharmaceutical industry and integration strategy alliance while iterating innovation, high-throughput, automation, and talent training as keys for breakthrough!

「今日奈捷消息分享」CDMO，毫無疑問是國際生物醫藥新主流，發展浪潮正起，「奈捷生技」& CDMO大廠台康生技& Sartorius 國際製藥設備大廠，接受環球月刊和財團法人生物技術開發中心邀請，進行產業分享與整合策略聯盟的契機！

突破臺灣CDMO發展創新、高通量、自動化、人力培養為關鍵
https://reurl.cc/mLo6NG